DOCTOR HOME since
Welcome to patients with chronic viral hepatitis
B or C and to their loved ones.
is a polymerase inhibitor that is combined
with ribavirin for treatment of patients with genotype 2
and genotype 3 patients. Genotype 2
patients are treated 12 weeks. Genotype 3 patients are treated
24 weeks. Pegasys or
PegIntron is added for patients with genotype 1, 4, 5 and 6 and treatment
If you cannot take Pegasys or
PegIntron, Sovaldi and ribavirin can be given for 24 weeks with very good
results as demonstrated in the
PHOTON Study. Sovaldi does not have the
drug interaction problems
and rash found with Incivek (telaprevir), a protease inhibitor.
If you are cured, your viral level falls to
during treatment and stays undetectable for the rest of your life, after
you stop the
HCV-RNA becomes detectable in your blood, you were not cured. If your
is undetectable 6 months after
completion of treatment, you have a 99%
chance of permanent cure.
Liver damage stops and liver healing starts. This improves survival and often restores health.
You can read the PDF file of my
poster from AASLD, that demonstrates improved survival
HCV is cured.
PDF file of AASLD poster
I am a board certified in internal medicine and gastroenterology.
In addition, I completed 2 years of
residency in pathology at Duke University Medical Center. I have been
a physician for 36 years.
I spend about 95% of my time treating patients with chronic viral hepatitis
C. I enjoy helping as many
patients as possible cure this infection.
The combination of Sovaldi and Olysio for 12 weeks is
effective in curing large numbers of
patients with HCV even with cirrhosis. The
proved that ribavirin and interferon
would soon be unnecessary in the treatment of HCV.
is replacing Incivek and Victrelis.
My office: 1009A Dupont Square North, Louisville KY 40207 phone:
The CDC now recommends that
Americans born between 1945 and 1965 be tested one time for HCV.
One third of persons with HCV die from
complications of cirrhosis. We can lower the death rate
from HCV if we are aggressive in identifying infected patients. Cure the
curable patients and lower
the death toll. Five million Americans are infected.
I am an advocate for patients infected with HCV. The
medical insurance companies place too many
obstacles to block patients
from going on or staying on the medications. I have seen many curable
patients fail because of this. Medicaid
cancels Rx .
Stage 3 and stage 4 HCV liver disease is life threatening and
should be covered like cancer treatment,
coronary artery bypass surgery
and kidney dialysis. HCV cirrhosis is just as deadly as these other
life-threatening diseases. Insurance companies should not discriminate against treatment
just as they are forbidden to discriminate against treatment of HIV/AIDS.
I can give information, but cannot
practice medicine over the internet. Patients with HCV should
a knowledgeable medical provider who treats large numbers of HCV infected
Bennet Cecil, MD
12/20/2013 07:38 PM